5-Amino-1MQ

MetabolicPRECLINICAL

Clinical Status

Preclinical Research.

Mechanism of Action

Inhibits NNMT, an enzyme that regulates NAD+ and SAM levels. Increases NAD+ availability, enhancing mitochondrial function, promoting fat oxidation, and supporting cellular energy metabolism.

Dosing Defaults

Dose

50-75 mg

Frequency

1x daily

Administration

Subcutaneous injection or oral

Timing

Morning, fasted

Food

fasted

Duration

4-6 weeks

Dose range: 50-100 mg daily

Morning dosing aligns with metabolic activity peaks.

Side Effects

•Mild headache
•Nausea
•Increased alertness
•Insomnia (rare)
•Elevated blood pressure (rare)

Contraindications & Warnings

•Not medical advice

Compare

Compare 5-Amino-1MQ with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your 5-Amino-1MQ dose.

Open Calculator

Related Metabolic Peptides

AICAR

PHASE 2

Metabolic

AMPK activator known as an "exercise mimetic." Enhances endurance capacity.

Adipotide

PRECLINICAL

Metabolic

Vascular-targeting peptide that destroys blood supply to fat tissue.

Tesofensine

PHASE 3

Metabolic

Triple monoamine reuptake inhibitor for appetite suppression and thermogenesis.

Setmelanotide

FDA APPROVED

Metabolic

MC4R agonist for rare genetic obesity. FDA-approved for specific mutations.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.